Attached files
| file | filename |
|---|---|
| EX-4.4 - EX-4.4 DESCRIPTION OF SECURITIES REGISTERED UNDER SECTION 12 OF THE SECURITIES E - Apellis Pharmaceuticals, Inc. | apls-ex44_92.htm |
| EX-32.2 - EX-32.2 - Apellis Pharmaceuticals, Inc. | apls-ex322_6.htm |
| EX-32.1 - EX-32.1 - Apellis Pharmaceuticals, Inc. | apls-ex321_8.htm |
| EX-31.2 - EX-31.2 - Apellis Pharmaceuticals, Inc. | apls-ex312_11.htm |
| EX-31.1 - EX-31.1 - Apellis Pharmaceuticals, Inc. | apls-ex311_7.htm |
| EX-23.2 - EX-23.2 CONSENT OF EY - Apellis Pharmaceuticals, Inc. | apls-ex232_147.htm |
| EX-23.1 - EX-23.1 - Apellis Pharmaceuticals, Inc. | apls-ex231_10.htm |
| 10-K - 10-K - Apellis Pharmaceuticals, Inc. | apls-10k_20191231.htm |
Exhibit 21.1
SUBSIDIARIES OF APELLIS PHARMACEUTICALS, INC.
|
|
|
|
|
Subsidiary |
|
Jurisdiction of Incorporation or Organization |
|
Apellis Australia Pty Ltd. |
|
Australia |
|
Apellis Ireland Ltd. |
|
Ireland |
|
Apellis Switzerland GmbH |
|
Switzerland |
|
Apellis MA Securities Inc. |
|
United States |